Go Pro
→ The Starlink of Energy (From Monument Traders Alliance) (Ad)tc pixel Free TRDA Stock Alerts

Entrada Therapeutics (TRDA) Earnings Date, Estimates & Call Transcripts

Entrada Therapeutics logo
$7.39 -0.06 (-0.81%)
As of 03:45 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Entrada Therapeutics Earnings Summary

Entrada Therapeutics announced Q2 2026 earnings on August 5, 2026, reporting an EPS of -$1.01, which missed the consensus estimate of -$0.97 by $0.04. Quarterly revenue was reported to be $0.90 million, below the consensus estimate of $2.32 million. With a trailing EPS of -$3.96, Entrada Therapeutics' earnings are expected to grow next year, from ($4.04) to ($3.65) per share.

Latest Q2
Earnings Date
Aug. 5Estimated
Consensus EPS
(Aug. 5)
-$0.97
Actual EPS
(Aug. 5)
-$1.01 Missed By -$0.04
Actual Revenue
(Aug. 5)
$0.90M

Q2 2026 Earnings Resources

Powered by Quartr
Get Entrada Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Entrada Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TRDA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TRDA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Entrada Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$1.32-$0.80-$1.08
Q2 20263-$1.38-$0.83-$1.13
Q3 20263-$1.45-$0.88-$1.17
Q4 20263-$1.51-$0.93-$1.16
FY 2026 12 -$5.66 -$3.44 -$4.54
Q1 20271-$0.79-$0.79-$0.79
Q2 20271-$0.71-$0.71-$0.71
Q3 20271-$0.78-$0.78-$0.78
Q4 20271-$0.86-$0.86-$0.86

Entrada Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026-$0.9738-$1.01 -$0.0363-$1.01$2.32M$0.90M
5/7/2026Q1 2026-$1.06-$0.95+$0.11-$0.95$2.92M$0.88M
2/26/2026Q4 2025-$1.32-$0.94+$0.38-$0.94$7.41M$1.30M
11/6/2025Q3 2025-$1.04-$1.06 -$0.02-$1.06$8.62M$1.61M
8/6/2025Q2 2025-$0.86-$1.04 -$0.18-$1.04$8.17M$1.98M
5/8/2025Q1 2025-$0.78-$0.42+$0.36-$0.42$10.98M$8.75M
2/27/2025Q4 2024-$0.66$0.03+$0.69$0.03$11.95M$12.25M

Entrada Therapeutics Earnings - Frequently Asked Questions

Entrada Therapeutics (NASDAQ:TRDA) last announced its quarterly earning data on Wednesday, August 5, 2026. Learn more on TRDA's earnings history.

In the previous quarter, Entrada Therapeutics (NASDAQ:TRDA) missed the analysts' consensus estimate of ($0.97) by $0.04 with a reported earnings per share (EPS) of ($1.01). Learn more on analysts' earnings estimate vs. TRDA's actual earnings.

Entrada Therapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

Entrada Therapeutics (NASDAQ:TRDA) has a recorded annual revenue of $25.42 million.

Entrada Therapeutics (NASDAQ:TRDA) has a recorded net income of -$143.75 million. TRDA has generated -$3.96 earnings per share over the last four quarters.

Entrada Therapeutics' earnings are expected to grow from ($4.04) per share to ($3.65) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:TRDA is sourced from Fiscal.ai, with the most recent quarter reported on 8/5/2026. New results are added as companies report their earnings.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...
Decentralized Masters | Sponsoredtc pixel